Home > Our company > Overview


____ is a clinical stage biotechnology ( biopharmacetical ) company focus on cell therapy and soluble protein drugs for hematological cancers and solid tumors. ___ is committed to the benefit of human health through technological innovation and market transformation.


Beike and Abigene co-founded _____ through M&A and restructing.


Founded on the vision that MAR is a new generation of specific antibodies against the "MHC" of binding antigenic peptides that can identify the cell surface and intracellular targeting compared with conventional CAR , we are developing MAR technology platform and applications in cell therapy and soluble protein drugs to recognize and kill cancer cells , which occupies an important position in the international immunotherapy and has broad application prospects.


Innovative core technology

Rapid clinical translation

Global development and partnering